M E Reynolds1, H T T Phan2,3,4, S George2, A T M Hubbard2, N Stoesser2, I E Maciuca5, D W Crook2,3, D Timofte5,6. 1. Axiom Veterinary Laboratories Ltd, The Manor House, Brunel Road, Newton Abbot, UK. 2. Modernising Medical Microbiology Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK. 3. National Institute for Health Research (NIHR) Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, UK. 4. NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK. 5. Institute of Veterinary Science, University of Liverpool, Leahurst Campus, Cheshire, UK. 6. Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Abstract
BACKGROUND/ OBJECTIVES: Carbapenemase-producing Enterobacteriaceae (CPE) are a public health threat, and have been found in humans, animals and the environment. Carbapenems are not authorized for use in EU or UK companion animals, and the prevalence of carbapenem-resistant Gram-negative bacilli (CRGNB) in this population is unknown. METHODS: We investigated CRGNB isolated from animal specimens received by one diagnostic laboratory from 34 UK veterinary practices (September 2015-December 2016). Any Gram-negative isolates from clinical specimens showing reduced susceptibility to fluoroquinolones and/or aminoglycosides and/or cephalosporins were investigated phenotypically and genotypically for carbapenemases. A complete genome assembly (Illumina/Nanopore) was generated for the single isolate identified to investigate the genetic context for carbapenem resistance. RESULTS: One ST410 Escherichia coli isolate [(CARB35); 1/191, 0.5%], cultured from a wound in a springer spaniel, harboured a known carbapenem resistance gene (blaNDM-5). The gene was located in the chromosome on an integrated 100 kb IncF plasmid, also harbouring other drug resistance genes (mrx, sul1, ant1 and dfrA). The isolate also contained blaCMY-42 and blaTEM-190 on two separate plasmids (IncI1 and IncFII, respectively) that showed homology with other publicly available plasmid sequences from Italy and Myanmar. CONCLUSIONS: Even though the use of carbapenems in companion animals is restricted, the concurrent presence of blaCMY-42 and other antimicrobial resistance genes could lead to co-selection of carbapenemase genes in this population. Further studies investigating the selection and flow of plasmids carrying important resistance genes amongst humans and companion animals are needed.
BACKGROUND/ OBJECTIVES: Carbapenemase-producing Enterobacteriaceae (CPE) are a public health threat, and have been found in humans, animals and the environment. Carbapenems are not authorized for use in EU or UK companion animals, and the prevalence of carbapenem-resistant Gram-negative bacilli (CRGNB) in this population is unknown. METHODS: We investigated CRGNB isolated from animal specimens received by one diagnostic laboratory from 34 UK veterinary practices (September 2015-December 2016). Any Gram-negative isolates from clinical specimens showing reduced susceptibility to fluoroquinolones and/or aminoglycosides and/or cephalosporins were investigated phenotypically and genotypically for carbapenemases. A complete genome assembly (Illumina/Nanopore) was generated for the single isolate identified to investigate the genetic context for carbapenem resistance. RESULTS: One ST410 Escherichia coli isolate [(CARB35); 1/191, 0.5%], cultured from a wound in a springer spaniel, harboured a known carbapenem resistance gene (blaNDM-5). The gene was located in the chromosome on an integrated 100 kb IncF plasmid, also harbouring other drug resistance genes (mrx, sul1, ant1 and dfrA). The isolate also contained blaCMY-42 and blaTEM-190 on two separate plasmids (IncI1 and IncFII, respectively) that showed homology with other publicly available plasmid sequences from Italy and Myanmar. CONCLUSIONS: Even though the use of carbapenems in companion animals is restricted, the concurrent presence of blaCMY-42 and other antimicrobial resistance genes could lead to co-selection of carbapenemase genes in this population. Further studies investigating the selection and flow of plasmids carrying important resistance genes amongst humans and companion animals are needed.
Authors: Aurélien Nigg; Michael Brilhante; Valentina Dazio; Mathieu Clément; Alexandra Collaud; Stefanie Gobeli Brawand; Barbara Willi; Andrea Endimiani; Simone Schuller; Vincent Perreten Journal: Euro Surveill Date: 2019-09
Authors: David A Singleton; Pisut Pongchaikul; Shirley Smith; Rebecca J Bengtsson; Kate Baker; Dorina Timofte; Stephen Steen; Matthew Jones; Larry Roberts; Fernando Sánchez-Vizcaíno; Susan Dawson; P-J M Noble; Alan D Radford; Gina L Pinchbeck; Nicola J Williams Journal: Front Microbiol Date: 2021-07-30 Impact factor: 5.640
Authors: Emanuela Roscetto; Chiara Varriale; Umberto Galdiero; Camilla Esposito; Maria Rosaria Catania Journal: Int J Environ Res Public Health Date: 2021-12-08 Impact factor: 3.390